Reacción #89903

ord-ed1e2bdb01f440f68adfb6a9c48e0b2e

Condiciones de reacción

Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    ConcentraciónThe solution was concentrated in vacuo
  2. 2
    Otrothe crude product was triturated with ether
  3. 3
    Filtraciónfiltered
  4. 4
    Otrodried under vacuum

Procedimiento

TFA (4 mL) was added to 5-(2-[(3-phenyl)phenyl)-7-methoxy-6-(2-(4-methylpiperazin-1-yl)ethoxy)quinazolin-4-ylamino)-1H-indazole-1-carboxylate and the reaction was stirred at RT for 1.5 h. The solution was concentrated in vacuo and the crude product was triturated with ether and filtered, dried under vacuum to give 2-[(3-phenyl)phenyl)-N-(1H-indazol-5-yl)-7-methoxy-6-(2-(4-methylpiperazin-1-yl)ethoxy)quinazolin-4-amine (0.166 g, 0.283 mmole, 64% over two steps). MS 586.4 (M+1). HPLC retention time 5.06 mins.

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US09440961B2uspto-grants-2016_09